Overview

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of coadministered Irbesartan and Atorvastatin in patients with hypertension and hyperlipidemia.
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Atorvastatin
Atorvastatin Calcium
Irbesartan